Monsanto Announces Global Genome-Editing Licensing Agreement With Broad Institute For Newly-Characterized CRISPR System
Monsanto Company announced that it has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system represents an exciting advance...